XBIvsIBBETF Comparison
VS
State Street SPDR S&P Biotech ETF (XBI) and iShares Biotechnology ETF (IBB) belong to the same industry segment: US Health Care. XBI's top 2 sector exposures are Healthcare and Finance. In contrast, IBB's top sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. XBI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.44% for IBB. XBI is up 24.65% year-to-date (YTD) with +$246M in YTD flows. IBB performs worse with 12.69% YTD performance, and -$34M in YTD flows. Run a side-by-side ETF comparison of XBI and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XBI vs IBB performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 08/04/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XBI IBB | -5.46%-2.68% | +13.84%+11.67% | +24.65%+12.69% | +75.70%+40.71% | +88.25%+50.51% | +22.35%+11.80% |
| Flows | XBI IBB | -$370M+$114M | +$337M+$309M | +$246M-$34M | +$1.17B+$1.34B | -$777M-$947M | +$1.25B-$1.89B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XBI IBB | +31.16%+22.46% | +27.14%+20.47% | +27.98%+20.48% | +32.91%+22.31% |
| Max drawdown | XBI IBB | -10.46%-6.21% | -10.46%-9.61% | -32.94%-24.82% | -54.07%-39.75% |
| Max drawdown duration | XBI IBB | 26d28d | 26d151d | 331d377d | 1685d1611d |
Trading data
XBI | IBB | |
Last sale 8/5/2026 at 6:26 PM | $152.69 | $191.43 |
| Previous close 08/04/2026 | $151.88 | $190.15 |
| Consolidated volume 08/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of July 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XBI | IBB | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 8/5/2026 at 6:26 PM
Live
Closed
XBI | IBB | |
|---|---|---|
| Last price | $152.69 | $191.43 |
| 1D performance | +0.53% | +0.67% |
| AuM | $9.96 B | $9.31 B |
| E/R | 0.35% | 0.44% |
Characteristics
XBI | IBB | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | iShares |
| Benchmark | S&P Biotechnology Select Industry Index | ICE Biotechnology Index |
| N° of holdings | 150 | 242 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 31, 2006 | February 5, 2001 |
| ESG | No | No |
Advertisement
Exposure
Countries
XBI
USA
95.06%
Other
4.94%
IBB
USA
86.15%
Other
13.85%
Sectors
XBI
Healthcare
99.03%
Other
0.97%
IBB
Healthcare
99.89%
Other
0.11%
Advertisement
Diversification
XBI
Total weight of top 15 holdings out of 15
19.19%
IBB
Total weight of top 15 holdings out of 15
53.71%
Top 15 holdings
Data as of June 30, 2026
XBI
Apogee Therapeutics, Inc.
1.48%
Moderna, Inc.
1.41%
Twist Bioscience Corp.
1.40%
Oruka Therapeutics, Inc.
1.37%
Kymera Therapeutics, Inc.
1.35%
Viking Therapeutics, Inc.
1.30%
Praxis Precision Medicines, Inc.
1.29%
Erasca, Inc.
1.27%
Revolution Medicines, Inc.
1.20%
Rhythm Pharmaceuticals, Inc.
1.20%
CG Oncology, Inc.
1.20%
SELLAS Life Sciences Group, Inc.
1.19%
Vaxcyte, Inc.
1.18%
Dianthus Therapeutics, Inc.
1.18%
Cytokinetics, Inc.
1.17%
IBB
Vertex Pharmaceuticals, Inc.
8.07%
Amgen, Inc.
7.82%
Gilead Sciences, Inc.
6.83%
Regeneron Pharmaceuticals, Inc.
4.90%
argenx SE
3.75%
Alnylam Pharmaceuticals, Inc.
3.12%
Natera, Inc.
2.89%
Revolution Medicines, Inc.
2.78%
Biogen, Inc.
2.46%
Illumina, Inc.
2.07%
Moderna, Inc.
1.98%
Insmed, Inc.
1.78%
BeOne Medicines Ltd.
1.77%
Incyte Corp.
1.75%
United Therapeutics Corp.
1.73%
Frequently asked questions about XBI and IBB
How have the XBI and IBB ETFs performed in 2026?
As of August 4, 2026, XBI is up 24.65% year-to-date (YTD), while IBB has returned 12.69%. That puts XBI better performer ahead so far this year.
Which ETF is attracting more investor money: XBI or IBB?
Year-to-date, the XBI ETF saw +$246M in flows, compared to -$34M for IBB.
Which ETF is more volatile: XBI or IBB?
Over the past year, XBI had a volatility of 27.14%, while IBB experienced 20.47%.
Which ETF is bigger: XBI or IBB?
As of August 4, 2026, XBI holds $9.96 B in assets under management (AUM), while IBB manages $9.31 B.
What sectors do the XBI and IBB ETFs invest in?
XBI leans toward sectors like Healthcare. Meanwhile, IBB focuses on Healthcare.
What are the top holdings of the XBI ETF and IBB ETF?
XBI top holdings include Apogee Therapeutics, Inc., Moderna, Inc. and Twist Bioscience Corp.. IBB holds in its top three: Vertex Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc..
Which ETF is more diversified: XBI or IBB?
XBI holds 153 securities with 19.19% of its assets in the top 15. IBB has 242 securities and a top 15 weight of 53.71%.
Advertisement
Advertisement
